Stryker, Johnson & Johnson and Zimmer Biomet posted their first-quarter financial results for 2024 and data on their orthopedic sales.
Here is how they compare:
Total sales: $5.2 billion (+9.7%)
Orthopedics: $2.2 billion (+7.5%)
Hips: $393 million (+5.1%)
Knees: $588 million (+4%)
Spine: $300 million (+5.5%)
Total sales: $1.9 billion (+3.2%)
Hips: $491.2 million (+0.3%)
Knees: $788.1 million (+3.2%)
Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $452.6 million (+4.4%)
Total sales: $21.4 billion (+2.3%)
Orthopedic: $2.3 billion (+4.3%)
Spine, sports and other: $752 million (+3.2%)
Hips: $422 million (+8.1%)
Knees: $401 million (+9%)